Episode Details
Back to Episodes
Pharmaceutical Executive Daily: FDA Approves Hernexeos
Published 2 months, 3 weeks ago
Description
In today’s Pharmaceutical Executive Daily, the FDA approves Hernexeos under a national priority voucher program, industry leaders explore the expansion of direct-to-consumer HIV prevention strategies, and Dupixent gains FDA approval for allergic fungal rhinosinusitis.